ストックスクリーナーアプリを入手
20.64
2.08%
0.42
アフターアワーズ：
20.80
0.16
+0.78%
前日終値:
$20.22
開ける：
$20.17
24時間の取引高:
1.11M
Relative Volume:
1.41
時価総額：
$1.53B
収益：
-
当期純損益:
$-64.16M
株価収益率:
-16.25
EPS:
-1.2702
ネットキャッシュフロー:
$-69.06M
1週間 パフォーマンス:
+17.07%
1か月 パフォーマンス:
-25.41%
6か月 パフォーマンス:
-43.85%
1年 パフォーマンス:
-43.31%
1日の値動き範囲:
$20.09
$21.16
1週間の範囲:
$17.10
$21.16
52週間の値動き範囲:
$14.80
$46.99
Cg Oncology Inc Stock (CGON) Company Profile
CGON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
20.64 | 1.53B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-09-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2024-06-28 | 開始されました | BofA Securities | Buy |
| 2024-02-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 開始されました | Goldman | Neutral |
| 2024-02-20 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-14 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Cg Oncology Inc (CGON) 最新ニュース
CG Oncology (NASDAQ:CGON) Coverage Initiated at Scotiabank - Defense World
Geode Capital Management LLC Has $33.18 Million Stock Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology initiated with a Sector Perform at Scotiabank - TipRanks
Scotiabank Initiates Coverage of CG Oncology (CGON) with Sector Perform Recommendation - Nasdaq
Scotiabank Initiates CG Oncology at Sector Perform With $23 Price Target - MarketScreener
CG Oncology (CGON) vs. Its Competitors Financial Comparison - Defense World
KLP Kapitalforvaltning AS Takes $100,000 Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Receives Average Rating of “Buy” from Analysts - Defense World
CG Oncology stock hits 52-week low at $15.7 amid market challenges - Investing.com UK
CG Oncology’s SWOT analysis: bladder cancer stock races against competition By Investing.com - Investing.com South Africa
CG Oncology's SWOT analysis: bladder cancer stock races against competition - Investing.com
CG Oncology’s SWOT analysis: bladder cancer stock races against competition - Investing.com India
CG Oncology's SWOT analysis: bladder cancer stock races against competition By Investing.com - Investing.com South Africa
Vanguard Group Inc. Has $168.10 Million Stock Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Reviewing CG Oncology (CGON) and Its Competitors - Defense World
Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade - MSN
Q1 Earnings Estimate for CG Oncology Issued By HC Wainwright - Defense World
Cantor Fitzgerald Weighs in on CG Oncology FY2025 Earnings - Defense World
HC Wainwright Forecasts CG Oncology FY2029 Earnings - Defense World
CG Oncology Looks Attractive At Current Prices (Rating Upgrade) (NASDAQ:CGON) - Seeking Alpha
Teacher Retirement System of Texas Acquires Shares of 11,927 CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Relative Strength Alert For CG Oncology - Nasdaq
CG Oncology stock hits 52-week low at $23.9 amid challenges - Investing.com UK
CG Oncology (NASDAQ:CGON) Receives “Buy” Rating from HC Wainwright - Defense World
HC Wainwright maintains CG Oncology stock Buy rating, $75 target By Investing.com - Investing.com Canada
Practice-Changing Bladder Cancer Results: Key BOND-003 Trial Data Revealed at Major Urology Conference - Stock Titan
CG Oncology announces mixed shelf offering - MSN
CG Oncology Advances in Bladder Cancer Therapeutics - MSN
CG Oncology Full Year 2024 Earnings: Misses Expectations - Yahoo
CG Oncology Inc Files For Mixed Shelf Offering Size Not Disclosed- SEC Filing - MarketScreener
CG Oncology, Inc. SEC 10-K Report - TradingView
CG Oncology Reports 2024 Year End Financial Results And Provides Business Updates - Marketscreener.com
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates - The Manila Times
Swiss National Bank Has $2.28 Million Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Is CG Oncology (CGON) Among the Best IPO Stocks to Buy in 2025? - Insider Monkey
CG Oncology’s (CGON) Buy Rating Reaffirmed at HC Wainwright - Defense World
H.C. Wainwright maintains CG Oncology buy with $75 target By Investing.com - Investing.com Australia
H.C. Wainwright maintains CG Oncology buy with $75 target - Investing.com India
Expert Outlook: CG Oncology Through The Eyes Of 4 Analysts - Benzinga
CG Oncology Shares Rise After Reporting Bladder Cancer Drug Durability in Phase 3 Trial - Marketscreener.com
Cretostimogene shows promise in bladder cancer study By Investing.com - Investing.com Australia
Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund - Endpoints News
Cretostimogene shows promise in bladder cancer study - Investing.com India
CG Oncology Reports Promising BOND-003 Data: 75.5% Complete Response Rate for Cretostimogene in Bladder Cancer Treatment - Nasdaq
Breakthrough: Novel Bladder Cancer Drug Shows 75% Response Rate with 28-Month Durability - Stock Titan
CG Oncology, Inc. (NASDAQ:CGON) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Bank of New York Mellon Corp Decreases Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (CGON) Expected to Announce Quarterly Earnings on Tuesday - Defense World
CG Oncology (NASDAQ:CGON) Stock Price Up 7.3% – Time to Buy? - Defense World
11,853 Shares in CG Oncology, Inc. (NASDAQ:CGON) Purchased by Arizona State Retirement System - Defense World
Cg Oncology Inc (CGON) 財務データ
収益
当期純利益
現金流量
EPS
2.51%
大文字化:
|
ボリューム (24 時間):